You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0069 A RAPID3-like index documents superior efficacy of BARICITINIB to ADALIMUMAB and placebo, similar to DAS28 and CDAI in the RA-BEAM clinical trial in patients with rheumatoid arthritis

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
SAT0069 A RAPID3-like index documents superior efficacy of BARICITINIB to ADALIMUMAB and placebo, similar to DAS28 and CDAI in the RA-BEAM clinical trial in patients with rheumatoid arthritis
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017101
Jul 20172202
Aug 20171200
Sep 20173002
Oct 20171402
Nov 20171600
Dec 20171401
Jan 20182206
Feb 20181400
Mar 20181201
Apr 20183200
May 20183001
Jun 2018601
Jul 2018600
Aug 20181601
Sep 20181001
Oct 20181001
Nov 20181004
Dec 20181003
Jan 20191503
Feb 2019704
Mar 2019202
Apr 2019604
May 20191003
Jun 2019801
Jul 20191206
Aug 20191405
Sep 2019801
Oct 2019604
Nov 2019403
Dec 20191003
Jan 2020901
Feb 2020503
Mar 2020201
Apr 20201503
May 2020602
Jun 2020704
Jul 2020601
Aug 2020805
Sep 20201001
Oct 2020602
Nov 202021010
Dec 2020702
Jan 2021402
Feb 2021001
Mar 2021403
Apr 2021400
May 2021105
Jul 2021003
Aug 2021104
Sep 2021002
Oct 20212012
Nov 20212010
Dec 2021601
Jan 2022200
Feb 2022401
Mar 20222004
Apr 20221402
May 20228010
Jun 20221403
Jul 20221000
Aug 2022804
Sep 2022608
Oct 2022603
Nov 2022408
Dec 20221001
Jan 2023204
Feb 2023501
Mar 20231402
Apr 2023400
May 2023002
Jun 2023001
Jul 2023403
Aug 2023002
Sep 2023400
Oct 2023002
Dec 20231200
Jan 2024200
Feb 2024202
Mar 2024402
Total6740209